9 completed, 9 terminated, 4 active not recruiting, 2 recruiting. 10 Not applicable, 8 Phase 2, 7 Phase 1, 1 Phase 3.
Follow Stage IV Lung Cancer: new trials by email Literature Review of Stage IV Lung Cancer trials Research Report on Stage IV Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Randomized Clinical Trial of Informational Support Versus Spiritual Care Spiritual Care, Informational Support - Stage IV Lung Cancer, Stage IV Gastrointestinal Cancer | Not applicable | Active not recruiting | Indiana University | 43 | 2025-09-09 | 2026-10-28 |
| Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors Telephone based interview, Survey using a questionnaire., Electronic health record review - Stage I Lung Cancer, Stage II Lung Cancer | Not applicable | Terminated | Wake Forest University Health Sciences | 5 | 2025-06-11 | 2026-10-22 |
| Shortened High-dose Palliative Radiotherapy for Lung Cancer Radiotherapy - Stage IV Lung Cancer | Not applicable | Active not recruiting | University Hospitals Coventry and Warwickshire NHS Trust | 37 | 2024-11-27 | 2026-10-26 |
| A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources Support for Caregiver - Generic List, Support for Caregiver - Personalized List, Internet-Based Intervention - CONNECT - Stage II Lung Cancer, Stage III Lung Cancer | Not applicable | Active not recruiting | Wake Forest University Health Sciences | 216 | 2024-11-11 | 2026-09-25 |
| Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs Stage III Breast Cancer, Stage IV Breast Cancer | Withdrawn | Travera Inc | 2024-11-01 | 2024-11-25 | ||
| An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer Radioconjugate, Positron Emission Tomography, Computed Tomography - Extensive-stage Small-cell Lung Cancer, Limited-stage Small-cell Lung Cancer | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2024-10-01 | 2024-09-27 | |
| Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients Osimertinib, Osimertinib + Chemotherapy - Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation | Active not recruiting | PrECOG, LLC. | 200 | 2024-09-17 | 2026-09-09 | |
| Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation Carboplatin, Atezolizumab, Etoposide - Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer | Phase 1 / Phase 2 | Recruiting | Vanderbilt-Ingram Cancer Center | 18 | 2024-04-24 | 2024-06-20 |
| Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer CIS-DPI - NSCLC (advanced Non-small Cell Lung Cancer), Stage IV Lung Cancer | Phase 1 / Phase 2 | Recruiting | Inhatarget Therapeutics | 32 | 2023-06-23 | 2025-03-26 |
| Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation Capmatinib, Trametinib - Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer | Phase 1 | Terminated | Collin Blakely | 3 | 2022-08-10 | 2024-06-11 |
| Ask Questions (ASQ):Implementation of a Communication Intervention Behavioral Intervention - Stage II Breast Cancer, Stage III Breast Cancer | Not applicable | Completed | Barbara Ann Karmanos Cancer Institute | 81 | 2021-08-25 | 2023-08-16 |
| Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer Binimetinib, Brigatinib - ALK Gene Rearrangement, Lung Non-Small Cell Carcinoma | Phase 1 | Terminated | University of California, San Francisco | 3 | 2020-02-25 | 2022-10-17 |
| Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites Canady Helios Cold Plasma Scalpel - Recurrent Malignant Solid Neoplasm, Stage IV Breast Cancer | Not applicable | Unknown | Jerome Canady, M.D. | 20 | 2019-07-30 | 2021-08-09 |
| Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer Stereotactic Body Radiation Therapy, Pembrolizumab - Metastatic Lung Cancer, Stage IV Lung Cancer | Phase 3 | Completed | Wake Forest University Health Sciences | 5 | 2019-06-24 | 2025-06-13 |
| Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners Cognitive Behavior Therapy, Quality-of-Life Assessment, Questionnaire Administration - Malignant Female Reproductive System Neoplasm, Malignant Hepatobiliary Neoplasm | Not applicable | Completed | Rutgers, The State University of New Jersey | 14 | 2017-12-06 | 2021-04-08 |
| Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients Early palliative care, Routine hospice care - Stage IV Breast Cancer, Stage IV Pancreatic Cancer | Completed | Seoul National University Hospital | 444 | 2016-12-17 | 2021-03-17 | |
| Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life Truthful information on chemotherapy risks, Standard of information - Stage IV Lung Cancer | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 123 | 2016-07-15 | 2025-11-20 |
| CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy CAPP-Seq, Isovue-200, Computed Tomography Perfusion Imaging - Malignant Lung Neoplasm, Metastatic Malignant Neoplasm in the Lung | Phase 1 | Completed | Stanford University | 19 | 2016-01-19 | 2023-11-22 |
| Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer Radiation Therapy (RT), MK-3475 - Head and Neck Squamous Cell Carcinoma, Metastatic Renal Cell Cancer | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 41 | 2015-02-05 | 2025-05-15 |
| A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations Lucitanib - Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer | Phase 2 | Terminated | Clovis Oncology, Inc. | 18 | 2014-04-01 | 2019-07-29 |
Showing 20 of 27. Sign in to see all of them.
Lung Neoplasms (27) · Carcinoma, Non-Small-Cell Lung (10) · Breast Neoplasms (5) · Prostatic Neoplasms (4) · Carcinoma, Renal Cell (3) · Colorectal Neoplasms (3) · Ovarian Neoplasms (3) · Pancreatic Neoplasms (3) · Small Cell Lung Carcinoma (3) · Urinary Bladder Neoplasms (3) · Uterine Cervical Neoplasms (3) · Colonic Neoplasms (2) · Liver Neoplasms (2) · Melanoma (2) · Stomach Neoplasms (2)
Lung Diseases (27) · Neoplasms by Site (27) · Respiratory Tract Diseases (27) · Respiratory Tract Neoplasms (27) · Thoracic Neoplasms (27) · Neoplasms (26) · Bronchial Neoplasms (10) · Carcinoma, Bronchogenic (10) · Digestive System Diseases (6) · Digestive System Neoplasms (6) · Gastrointestinal Diseases (6) · Skin Diseases (6) · Skin and Connective Tissue Diseases (6) · Breast Diseases (5) · Female Urogenital Diseases (5)
antineoplaston A10 (3) · antineoplaston AS 2-1 (3) · Carboplatin (2) · Magnetic Resonance Spectroscopy (2) · Radiotherapy (2) · pembrolizumab (2) · Behavior Therapy (1) · Cisplatin (1) · Cognitive Behavioral Therapy (1) · Cytidine Triphosphate (1) · Drug Therapy (1) · E-3810 (1) · Erlotinib Hydrochloride (1) · Etoposide (1) · Fulvestrant (1)
Burzynski Research Institute (3) · Wake Forest University Health Sciences (3) · Assistance Publique - Hôpitaux de Paris (1) · Barbara Ann Karmanos Cancer Institute (1) · Case Comprehensive Cancer Center (1) · Clovis Oncology, Inc. (1) · Collin Blakely (1) · Indiana University (1) · Inhatarget Therapeutics (1) · Intergroupe Francophone de Cancerologie Thoracique (1) · Jerome Canady, M.D. (1) · Massachusetts General Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · PrECOG, LLC. (1) · Roswell Park Cancer Institute (1)
United States (20) · France (4) · Spain (2) · Belgium (1) · Germany (1) · Italy (1) · South Korea (1) · United Kingdom (1)
Stanislaw R. Burzynski, MD, PhD (3) · Collin Blakely, MD, PhD (1) · Collin M Blakely, MD, PhD (1) · Evan Osmundson, MD, PhD (1) · Grace Dy, MD (1) · Jennifer Johnson, MD, PhD (1) · Kathryn Weaver, PhD (1) · Lecia V. Sequist, MD, MPH (1) · Leslie B Tyson, NO (1) · Mark Stevens, Ph.D. (1) · Maximilian Diehn (1) · Michael Farris, MD (1)
PMID 27663515, PMID 32144133, PMID 35802350, PMID 35844029, PMID 37509349, PMID 39582048, PMID 41628919, PMID 42364728
P30CA012197 (2), P30CA043703 (1), P30CA072720 (1)